Bloomberg the Company

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Follow Us

Industry Products

Swedish Orphan Biovitrum Shares Fall After Cutting Outlook

Don't Miss Out —
Follow us on:

Oct. 26 (Bloomberg) -- Swedish Orphan Biovitrum AB fell the most in more than a year in Stockholm trading after cutting its full-year forecast.

Swedish Orphan said sales will increase by 1 percent to 4 percent compared with its earlier forecast of 8 to 10 percent, because of weaker sales than expected in Europe. Shares in the Stockholm-based drugmaker fell as much as 8.2 percent, the steepest decline since July 2009, and were down 1.90 kronor, or 4.6 percent, to 39.50 kronor at 9:14 a.m. local time.

Link to Company News:{KARO SS <Equity> CN <GO>} Link to Company News:{SOBI SS <Equity> CN <GO>}

To contact the editor responsible for this story: Frances Schwartzkopff at fschwartzko1@bloomberg.net

Please upgrade your Browser

Your browser is out-of-date. Please download one of these excellent browsers:

Chrome, Firefox, Safari, Opera or Internet Explorer.